Brief: Immunovia Q4 Oper Loss SEK 16.7 Mln
24/02/2026 07:36
Feb 24 (Reuters) - Immunovia AB (publ) IMMNOV.ST: IMMUNOVIA Q4 ADJUSTED EPS SEK -0.03 NET SALES OF 354 KSEK, OPERATING LOSS OF 16.7 MSEK IN Q4 2025 Source text: ID:nMFNc6CZJT Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study